Clinical Trial Update: Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sitagliptin to placebo in adults with type 2 diabetes and inadequate glycemic control on metformin with pioglitazone has completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2012-02-01